Motivating Patients and Maintaining Rigor in Cardiovascular Clinical Trials
Cardiovascular research can feel like a “numbers game” from design and recruitment to analysis. Worldwide brings the experience, decisiveness and tailored solutions your program needs.
Dedicated cardiovascular teams, 30 years and counting
Worldwide wins the numbers game. We have more than three decades of experience in cardiovascular research, a presence in more than 60 countries, and extensive global trial experience in all phases of research—even involving more than 26,000 patients in a single trial. Yet every single program receives the attention and care of a dedicated team, enabling us to act quickly and effectively in close collaboration with key industry partners.
KAREN HILL
PRESIDENT OF CVM & EVIDENCE BUSINESS UNITS
Karen Hill, President of CVM & Evidence Business Units, has been with Worldwide Clinical Trials for more than 25 years, providing management and supervision to project managers and CRAs. Karen supervises global teams working on large cardiovascular outcome studies, as well as projects in other cardiovascular indications across all clinical trial phases.
ETERI TSETSKHLADZE, MD, PHD, FESC, FACC
VICE PRESIDENT, GENERAL MEDICINE MEDICAL LEAD, MEDICAL AFFAIRS
As a clinician, investigator, and educator, Dr. Tsetskhladze embodies Worldwide’s commitment to supporting improved health care options. Since joining the Worldwide Clinical Trials team in 2004, she has supported more than 70 studies in her capacity as medical director and therapeutic advisor. She combines scientific and clinical rigor with an intimate understanding of the patient’s experience, and is adept at translating medical and scientific findings into accessible data to serve commercial and regulatory objectives. Dr. Tsetskhladze is a fellow of the American College of Cardiology (ACC) and the European Society of Cardiology (ESC), while also serving on a number of therapeutic working groups. She is credited with more than 50 publications.
LUCY BENNETT
SENIOR DIRECTOR, PROJECT MANAGEMENT
Lucy Bennett, Senior Director of Project Management for the UK, has been a member of the Cardiometabolic group at Worldwide Clinical Trials for almost three decades. Her experience with data management, site management and monitoring, and project management brings an intimate understanding of sponsors’ needs. She currently provides global oversight of internal and external teams and vendors, with responsibilities bridging the full life span of the clinical trial, from start-up through maintenance and closure.
Extensive cardiovascular outcomes trial and adjudication experience
Our experience executing large cardiovascular trials has resulted in irreplaceable expertise: a solid understanding of the events, treatment, and outcomes of interest. These studies require event adjudication and close collaboration with Clinical Events Committees (CECs).
Cost-effectiveness through smart planning
Smart screening and high compliance rates reduce enrollment costs. Paired with thoughtful statistical analysis plans and early leading signals for rapid identification of struggling products, we offer shorter trials for patients and faster decision-making guidance for sponsors.
A different approach to recruitment & retention
Worldwide can do more than screen patients for inclusion and exclusion criteria. Using emerging predictive analytics technology, we identify the study subjects most likely to comply with the protocol and stay the course of the trial.
Respectful, people-focused study design
Worldwide minimizes attrition and improves statistical validity by anticipating the pain points most likely to cause attrition. We then proactively work to alleviate those concerns, honoring patients’ time and commitment through compressed timelines and reduced study burden.
Cultivating cardiovascular success stories one patient—and study—at a time
Cardiovascular trials often require teamwide dedication to a broad scope and a patient, detail-oriented operational approach. At Worldwide, we believe each study relies on the commitment of the individuals involved. Find out how this comes through in everything we do.
Cardiovascular Experience
- Acute Coronary Syndrome (ACS)
- Angina
- Anticoagulation
- Atherosclerosis
- Atrial Fibrillation
- Cardiac Arrhythmias
- Coronary Artery Disease (CAD)
- Heart Failure
- Hypertension
- Ischemic Heart Disease
- Myocardial Infarction
- Pulmonary Arterial Hypertension (PAH)
- Restenosis
- Stroke/Cerebrovascular Disease – Prevention
- Thrombosis
Our Dedicated Team
Eteri Tsetskhladze, MD, PhD, FESC, FACC
Vice President, General Medicine Medical Lead, Medical Affairs
Rafal Ziecina, MD, PhD
Executive Director, Scientific Solutions, Cardiovascular, Endocrine & Metabolic
